Related Experiment Video
Updated: Feb 20, 2026

10:52
Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
Published on: June 5, 2015
13.6K
Humanity in a Dish: Population Genetics with iPSCs.
Curtis R Warren1, Chad A Cowan2
1Division of Cardiovascular Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA.
Trends in Cell Biology
|October 22, 2017
Summary
Induced pluripotent stem cells (iPSCs) enable new population genetic studies by linking genotypes to cellular phenotypes. Future iPSC collections will advance understanding of common genetic variants and disease mechanisms.
Area of Science:
- Genetics
- Stem Cell Biology
- Genomics
Background:
- Induced pluripotent stem cells (iPSCs) are valuable for studying genotype-phenotype relationships.
- Recent studies utilize iPSC cohorts for in vitro quantitative trait locus (QTL) analyses.
- This represents a new paradigm in functional population genetics.
Purpose of the Study:
- To review advances in iPSC-based functional population genetic studies.
- To outline a roadmap for future research in this field.
- To explore the potential of iPSC studies for uncovering genetic variant effects and disease mechanisms.
Main Methods:
- Leveraging iPSC collections from large human cohorts.
- Performing in vitro quantitative trait locus (QTL) studies.
- Analyzing gene expression and cellular phenotypes.
Main Results:
- iPSC-derived cellular phenotypes can be linked to common genetic variants.
- This approach facilitates the discovery of molecular underpinnings of genetic diseases.
- In vitro QTL studies are emerging as a powerful tool.
Conclusions:
- iPSC-based functional population genetics offers a novel approach to understanding genetic variation.
- Large-scale iPSC collections are crucial for future discoveries.
- This field holds promise for personalized medicine and disease research.
Related Concept Videos
Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K

